Clinical Trial Detail

NCT ID NCT04049669
Title Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Theodore S. Johnson
Indications

glioblastoma multiforme

malignant ependymoma

medulloblastoma

brain stem glioma

Therapies

Cyclophosphamide + Etoposide + Indoximod

Indoximod + Lomustine + Temozolomide

Indoximod + Temozolomide

Indoximod

Age Groups: adult child

No variant requirements are available.